Advertisement

U.S. markets closed

S&P Futures
6,038.75
+0.50(+0.01%)
Dow Futures
44,990.00
+39.00(+0.09%)
Nasdaq Futures
20,977.00
-16.50(-0.08%)
Russell 2000 Futures
2,436.70
+4.30(+0.18%)
Crude Oil
68.80
+0.03(+0.04%)
Gold
2,640.30
+19.00(+0.72%)

Petros Pharmaceuticals, Inc. (PTPI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

0.2677

-0.0223

(-7.69%)

At close: 04:00PM EST

0.2650

-0.00

(-1.01%)

After hours:

07:22PM EST

Trade prices are not sourced from all markets

All

Simply Wall St.
Petros Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Petros Pharmaceuticals ( NASDAQ:PTPI ) Third Quarter 2024 Results Key Financial Results Revenue: US$1.58m (down 5.9...
ACCESSWIRE
Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)
Company is currently conducting larger scale comprehension test to confirm results in compliance with FDA discussions NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company ...